CAH
Cardinal Health, Inc.
Price Chart
Latest Quote
$228.52
-0.20 (-0.09%)
Current Price
| Previous Close | $228.72 |
| Open | $230.54 |
| Day High | $233.18 |
| Day Low | $228.43 |
| Volume | 1,407,118 |
Stock Information
| Quarterly Dividend / Yield | $2.05 / 0.90% |
| Shares Outstanding | 234.21M |
| Quarterly Dividend Yield | 0.90% |
| Quarterly Dividend | $2.05 |
| Total Debt | $8.92B |
| Cash Equivalents | $3.94B |
| Revenue | $250.74B |
| Net Income | $1.56B |
| Sector | Healthcare |
| Industry | Medical Distribution |
| Market Cap | $53.52B |
| P/E Ratio | 34.94 |
| EPS (TTM) | $6.54 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $58.66B |
| Sales | $250.74B |
| Income | $1.56B |
| Book/sh | $-12.05 |
| Cash/sh | $16.81 |
| Employees | 53K |
Financial Ratios
| Quick Ratio | 0.42 |
| Current Ratio | 0.91 |
| EPS Growth TTM | -21.10% |
Returns & Margins
| ROA | 3.60% |
| Gross Margin | 3.76% |
| Operating Margin | 1.41% |
| Profit Margin | 0.62% |
Ownership
| Insider Ownership | 0.26% |
| Institutional Ownership | 90.20% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 18.99 |
| PEG | 1.42 |
| P/S | 0.21 |
| P/B | -18.96 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $249.60 |
Technical Indicators
| SMA20 | $232.77 |
| SMA50 | $213.87 |
| SMA200 | $204.27 |
| RSI | 35.83 |
| ATR | 5.4386 |
| Shares Float | 233.73M |
| Short Float | 3.49% |
| Short Ratio | 2.91 |
| Volatility | 0.49 |
| Rel Volume | 0.80 |
Performance History
| Week | -3.09% |
| Month | +0.57% |
| Quarter | +7.47% |
| 6 Months | +7.50% |
| YTD | +11.59% |
| Year | +43.32% |
| 3 Years | +155.81% |
| 5 Years | +345.64% |
| 10 Years | +262.82% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-07-17 | $228.52 | 2,052,800 |
| 2026-07-16 | $228.72 | 2,607,800 |
| 2026-07-15 | $224.94 | 2,358,300 |
| 2026-07-14 | $230.11 | 3,127,400 |
| 2026-07-13 | $233.66 | 2,286,100 |
| 2026-07-10 | $235.80 | 2,842,600 |
| 2026-07-09 | $233.77 | 3,216,400 |
| 2026-07-08 | $237.15 | 2,693,600 |
| 2026-07-07 | $239.71 | 3,236,400 |
| 2026-07-06 | $237.52 | 2,477,000 |
| 2026-07-02 | $238.94 | 2,039,100 |
| 2026-07-01 | $237.72 | 1,369,700 |
| 2026-06-30 | $237.04 | 1,666,800 |
| 2026-06-29 | $235.71 | 1,926,600 |
| 2026-06-26 | $237.40 | 3,633,200 |
| 2026-06-25 | $234.24 | 2,074,000 |
| 2026-06-24 | $232.50 | 2,354,400 |
| 2026-06-23 | $228.41 | 2,110,400 |
| 2026-06-22 | $222.26 | 2,886,000 |
| 2026-06-18 | $221.29 | 4,196,100 |
About Cardinal Health, Inc.
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
đ° Latest News
Reasons to Retain Doximity Stock in Your Portfolio for Now
Zacks âĸ 2026-07-17T18:22:00Z
ISRG Q2 Earnings Beat Estimates, Stock Falls on Slow Procedure Growth
Zacks âĸ 2026-07-17T18:20:00Z
Stryker Launches Mako RPS to Expand Robotic Knee Surgery Portfolio
Zacks âĸ 2026-07-17T15:39:00Z
Here's Why You Should Retain INSP Stock in Your Portfolio for Now
Zacks âĸ 2026-07-17T14:50:00Z
Will Declining Membership Affect Molina Healthcare's Q2 Earnings?
Zacks âĸ 2026-07-17T14:44:00Z
GEHC Stock Up on $500M Strategic Care Alliance With Catholic Health
Zacks âĸ 2026-07-17T14:26:00Z
Reasons to Retain Cooper Companies Stock in Your Portfolio for Now
Zacks âĸ 2026-07-16T16:54:00Z
Can Higher Occupancy Offset Lower Admissions in CYH's Q2 Earnings?
Zacks âĸ 2026-07-16T16:53:00Z
Danaher Gears Up to Post Q2 Earnings: Is a Beat in the Offing?
Zacks âĸ 2026-07-16T15:46:00Z
Smith+Nephew Launches LYNX COBLATION Wand for ENT Airway Surgery
Zacks âĸ 2026-07-16T15:41:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $214,084,000,000 | $218,987,000,000 | $197,698,000,000 | $174,474,000,000 |
| Cost Of Revenue | $214,410,000,000 | $219,413,000,000 | $198,105,000,000 | $174,842,000,000 |
| Total Revenue | $222,578,000,000 | $226,827,000,000 | $204,979,000,000 | $181,326,000,000 |
| Operating Revenue | $222,578,000,000 | $226,827,000,000 | $204,979,000,000 | $181,326,000,000 |
| Expenses | ||||
| Interest Expense | $215,000,000 | $51,000,000 | $84,000,000 | $147,000,000 |
| Total Expenses | $220,256,000,000 | $224,697,000,000 | $203,190,000,000 | $179,678,000,000 |
| Other Income Expense | $-6,000,000 | $-878,000,000 | $-1,042,000,000 | $-2,285,000,000 |
| Other Non Operating Income Expenses | $41,000,000 | $9,000,000 | $-5,000,000 | $-22,000,000 |
| Net Non Operating Interest Income Expense | $-215,000,000 | $-51,000,000 | $-84,000,000 | $-147,000,000 |
| Interest Expense Non Operating | $215,000,000 | $51,000,000 | $84,000,000 | $147,000,000 |
| Operating Expense | $5,846,000,000 | $5,284,000,000 | $5,085,000,000 | $4,836,000,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $1,561,000,000 | $852,000,000 | $330,000,000 | $-938,000,000 |
| Net Interest Income | $-215,000,000 | $-51,000,000 | $-84,000,000 | $-147,000,000 |
| Normalized Income | $1,596,109,000 | $1,481,984,180 | $1,149,230,000 | $849,770,000 |
| Net Income From Continuing And Discontinued Operation | $1,561,000,000 | $852,000,000 | $330,000,000 | $-938,000,000 |
| Total Operating Income As Reported | $2,275,000,000 | $1,243,000,000 | $752,000,000 | $-607,000,000 |
| Net Income Common Stockholders | $1,561,000,000 | $852,000,000 | $330,000,000 | $-938,000,000 |
| Net Income | $1,561,000,000 | $852,000,000 | $330,000,000 | $-938,000,000 |
| Net Income Including Noncontrolling Interests | $1,569,000,000 | $853,000,000 | $331,000,000 | $-937,000,000 |
| Net Income Continuous Operations | $1,569,000,000 | $853,000,000 | $331,000,000 | $-937,000,000 |
| Pretax Income | $2,101,000,000 | $1,201,000,000 | $663,000,000 | $-784,000,000 |
| Special Income Charges | $-47,000,000 | $-887,000,000 | $-1,037,000,000 | $-2,263,000,000 |
| Operating Income | $2,322,000,000 | $2,130,000,000 | $1,789,000,000 | $1,648,000,000 |
| Depreciation Amortization Depletion Income Statement | $464,000,000 | $284,000,000 | $285,000,000 | $324,000,000 |
| Depreciation And Amortization In Income Statement | $464,000,000 | $284,000,000 | $285,000,000 | $324,000,000 |
| Amortization Of Intangibles Income Statement | $464,000,000 | $284,000,000 | $285,000,000 | $324,000,000 |
| Gross Profit | $8,168,000,000 | $7,414,000,000 | $6,874,000,000 | $6,484,000,000 |
| Per Share | ||||
| Diluted EPS | $6.45 | $3.45 | $1.00 | $-3.35 |
| Basic EPS | $6.48 | $3.48 | $1.00 | $-3.35 |
| Other | ||||
| Tax Effect Of Unusual Items | $-11,891,000 | $-257,015,820 | $-217,770,000 | $-475,230,000 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $3,153,000,000 | $2,849,000,000 | $2,476,000,000 | $2,318,000,000 |
| Total Unusual Items | $-47,000,000 | $-887,000,000 | $-1,037,000,000 | $-2,263,000,000 |
| Total Unusual Items Excluding Goodwill | $-47,000,000 | $-887,000,000 | $-1,037,000,000 | $-2,263,000,000 |
| Reconciled Depreciation | $790,000,000 | $710,000,000 | $692,000,000 | $692,000,000 |
| EBITDA (Bullshit earnings) | $3,106,000,000 | $1,962,000,000 | $1,439,000,000 | $55,000,000 |
| EBIT | $2,316,000,000 | $1,252,000,000 | $747,000,000 | $-637,000,000 |
| Diluted Average Shares | $242,000,000 | $247,000,000 | $262,000,000 | $279,000,000 |
| Basic Average Shares | $241,000,000 | $245,000,000 | $261,000,000 | $279,000,000 |
| Diluted NI Availto Com Stockholders | $1,561,000,000 | $852,000,000 | $330,000,000 | $-938,000,000 |
| Minority Interests | $-8,000,000 | $-1,000,000 | $-1,000,000 | $-1,000,000 |
| Tax Provision | $532,000,000 | $348,000,000 | $332,000,000 | $153,000,000 |
| Other Special Charges | $-185,000,000 | $78,000,000 | $-304,000,000 | $104,000,000 |
| Write Off | $18,000,000 | $634,000,000 | $1,246,000,000 | - |
| Restructuring And Mergern Acquisition | $214,000,000 | $175,000,000 | $95,000,000 | $101,000,000 |
| Amortization | $464,000,000 | $284,000,000 | $285,000,000 | $324,000,000 |
| Selling General And Administration | $5,382,000,000 | $5,000,000,000 | $4,800,000,000 | $4,512,000,000 |
| Gain On Sale Of Ppe | - | $-634,000,000 | $-1,250,000,000 | $-2,060,000,000 |
| Gain On Sale Of Business | - | $0 | $0 | $2,000,000 |
| Impairment Of Capital Assets | - | $634,000,000 | $1,246,000,000 | $2,060,000,000 |
Fetched: 2026-07-08
Balance Sheet (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-14,958,000,000 | $-9,663,000,000 | $-9,043,000,000 | $-8,338,000,000 |
| Total Assets | $53,122,000,000 | $45,121,000,000 | $43,349,000,000 | $43,878,000,000 |
| Total Non Current Assets | $16,749,000,000 | $10,237,000,000 | $9,612,000,000 | $10,943,000,000 |
| Other Non Current Assets | $1,714,000,000 | $1,258,000,000 | $1,066,000,000 | $953,000,000 |
| Goodwill And Other Intangible Assets | $12,177,000,000 | $6,450,000,000 | $6,085,000,000 | $7,629,000,000 |
| Other Intangible Assets | $2,908,000,000 | $1,725,000,000 | $1,472,000,000 | $1,774,000,000 |
| Current Assets | $36,373,000,000 | $34,884,000,000 | $33,737,000,000 | $32,935,000,000 |
| Other Current Assets | $2,414,000,000 | $2,663,000,000 | $2,294,000,000 | $2,021,000,000 |
| Assets Held For Sale Current | $12,000,000 | $47,000,000 | $140,000,000 | $0 |
| Inventory | $16,831,000,000 | $14,957,000,000 | $16,119,000,000 | $15,636,000,000 |
| Receivables | $13,242,000,000 | $12,084,000,000 | $11,108,000,000 | $10,561,000,000 |
| Accounts Receivable | $13,242,000,000 | $12,084,000,000 | $11,108,000,000 | $10,561,000,000 |
| Allowance For Doubtful Accounts Receivable | $-213,000,000 | $-233,000,000 | $-240,000,000 | $-273,000,000 |
| Gross Accounts Receivable | $13,455,000,000 | $12,317,000,000 | $11,348,000,000 | $10,834,000,000 |
| Cash Cash Equivalents And Short Term Investments | $3,874,000,000 | $5,133,000,000 | $4,076,000,000 | $4,717,000,000 |
| Cash And Cash Equivalents | $3,874,000,000 | $5,133,000,000 | $4,076,000,000 | $4,717,000,000 |
| Prepaid Assets | - | - | $2,362,000,000 | $2,021,000,000 |
| Debt | ||||
| Net Debt | $4,653,000,000 | - | $625,000,000 | $598,000,000 |
| Total Debt | $8,527,000,000 | $5,092,000,000 | $4,701,000,000 | $5,315,000,000 |
| Long Term Debt And Capital Lease Obligation | $7,977,000,000 | $4,658,000,000 | $3,909,000,000 | $4,735,000,000 |
| Long Term Debt | $7,977,000,000 | $4,658,000,000 | $3,909,000,000 | $4,735,000,000 |
| Current Debt And Capital Lease Obligation | $550,000,000 | $434,000,000 | $792,000,000 | $580,000,000 |
| Current Debt | $550,000,000 | $434,000,000 | $792,000,000 | $580,000,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $55,756,000,000 | $48,333,000,000 | $46,306,000,000 | $44,584,000,000 |
| Total Non Current Liabilities Net Minority Interest | $16,859,000,000 | $12,693,000,000 | $12,566,000,000 | $14,034,000,000 |
| Other Non Current Liabilities | $8,882,000,000 | $8,035,000,000 | $8,657,000,000 | $9,299,000,000 |
| Current Liabilities | $38,897,000,000 | $35,640,000,000 | $33,740,000,000 | $30,550,000,000 |
| Payables And Accrued Expenses | $38,347,000,000 | $35,206,000,000 | $32,906,000,000 | $29,970,000,000 |
| Payables | $34,713,000,000 | $31,759,000,000 | $29,934,000,000 | $27,128,000,000 |
| Accounts Payable | $34,713,000,000 | $31,759,000,000 | $29,934,000,000 | $27,128,000,000 |
| Non Current Deferred Liabilities | - | - | $8,653,000,000 | $9,299,000,000 |
| Non Current Deferred Taxes Liabilities | - | - | $8,653,000,000 | $9,299,000,000 |
| Other Current Liabilities | - | - | $42,000,000 | - |
| Equity | ||||
| Common Stock Equity | $-2,781,000,000 | $-3,213,000,000 | $-2,958,000,000 | $-709,000,000 |
| Total Equity Gross Minority Interest | $-2,634,000,000 | $-3,212,000,000 | $-2,957,000,000 | $-706,000,000 |
| Stockholders Equity | $-2,781,000,000 | $-3,213,000,000 | $-2,958,000,000 | $-709,000,000 |
| Gains Losses Not Affecting Retained Earnings | $-155,000,000 | $-167,000,000 | $-151,000,000 | $-114,000,000 |
| Other Equity Adjustments | $-155,000,000 | $-167,000,000 | $-151,000,000 | $-114,000,000 |
| Retained Earnings | $783,000,000 | $-286,000,000 | $-642,000,000 | $-280,000,000 |
| Other | ||||
| Treasury Shares Number | $32,000,000 | $83,000,000 | $76,000,000 | $54,000,000 |
| Ordinary Shares Number | $238,677,005 | $244,000,000 | $251,000,000 | $273,000,000 |
| Share Issued | $270,677,005 | $327,000,000 | $327,000,000 | $327,000,000 |
| Tangible Book Value | $-14,958,000,000 | $-9,663,000,000 | $-9,043,000,000 | $-8,338,000,000 |
| Invested Capital | $5,746,000,000 | $1,879,000,000 | $1,743,000,000 | $4,606,000,000 |
| Working Capital | $-2,524,000,000 | $-756,000,000 | $-3,000,000 | $2,385,000,000 |
| Total Capitalization | $5,196,000,000 | $1,445,000,000 | $951,000,000 | $4,026,000,000 |
| Minority Interest | $147,000,000 | $1,000,000 | $1,000,000 | $3,000,000 |
| Treasury Stock | $6,365,000,000 | $5,677,000,000 | $4,911,000,000 | $3,128,000,000 |
| Capital Stock | $2,956,000,000 | $2,917,000,000 | $2,746,000,000 | $2,813,000,000 |
| Common Stock | $2,956,000,000 | $2,917,000,000 | $2,746,000,000 | $2,813,000,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Current Accrued Expenses | $3,634,000,000 | $3,447,000,000 | $2,972,000,000 | $2,842,000,000 |
| Goodwill | $9,269,000,000 | $4,725,000,000 | $4,613,000,000 | $5,855,000,000 |
| Net PPE | $2,858,000,000 | $2,529,000,000 | $2,461,000,000 | $2,361,000,000 |
| Accumulated Depreciation | $-4,658,000,000 | $-4,166,000,000 | $-3,849,000,000 | $-3,522,000,000 |
| Gross PPE | $7,516,000,000 | $6,695,000,000 | $6,310,000,000 | $5,883,000,000 |
| Construction In Progress | $577,000,000 | $577,000,000 | $516,000,000 | $358,000,000 |
| Machinery Furniture Equipment | $4,761,000,000 | $4,239,000,000 | $4,005,000,000 | $3,801,000,000 |
| Properties | $2,178,000,000 | $1,879,000,000 | $1,789,000,000 | $1,724,000,000 |
| Land And Improvements | - | - | $1,785,000,000 | $1,724,000,000 |
Fetched: 2026-07-08
Cash Flow Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $1,850,000,000 | $3,251,000,000 | $2,363,000,000 | $2,788,000,000 |
| Operating Activities | ||||
| Operating Cash Flow | $2,397,000,000 | $3,762,000,000 | $2,844,000,000 | $3,175,000,000 |
| Cash Flow From Continuing Operating Activities | $2,397,000,000 | $3,762,000,000 | $2,844,000,000 | $3,175,000,000 |
| Operating Gains Losses | - | - | - | $8,000,000 |
| Investing Activities | ||||
| Capital Expenditure | $-547,000,000 | $-511,000,000 | $-481,000,000 | $-387,000,000 |
| Investing Cash Flow | $-5,593,000,000 | $-1,849,000,000 | $-454,000,000 | $567,000,000 |
| Cash Flow From Continuing Investing Activities | $-5,593,000,000 | $-1,849,000,000 | $-454,000,000 | $567,000,000 |
| Net Other Investing Changes | $2,000,000 | $18,000,000 | $8,000,000 | - |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-765,000,000 | $-750,000,000 | $-2,000,000,000 | $-1,000,000,000 |
| Financing Cash Flow | $1,940,000,000 | $-847,000,000 | $-3,051,000,000 | $-2,463,000,000 |
| Cash Flow From Continuing Financing Activities | $1,940,000,000 | $-847,000,000 | $-3,051,000,000 | $-2,463,000,000 |
| Net Other Financing Charges | $-25,000,000 | $46,000,000 | $53,000,000 | $-19,000,000 |
| Cash Dividends Paid | $-494,000,000 | $-499,000,000 | $-525,000,000 | $-559,000,000 |
| Common Stock Dividend Paid | $-494,000,000 | $-499,000,000 | $-525,000,000 | $-559,000,000 |
| Net Common Stock Issuance | $-765,000,000 | $-750,000,000 | $-2,000,000,000 | $-1,000,000,000 |
| Other | ||||
| Repayment Of Debt | $-445,000,000 | $-783,000,000 | $-579,000,000 | $-885,000,000 |
| Issuance Of Debt | $3,669,000,000 | $1,139,000,000 | $0 | $0 |
| Interest Paid Supplemental Data | $315,000,000 | $214,000,000 | $203,000,000 | $153,000,000 |
| Income Tax Paid Supplemental Data | $444,000,000 | $191,000,000 | $156,000,000 | - |
| End Cash Position | $3,874,000,000 | $5,133,000,000 | $4,076,000,000 | $4,745,000,000 |
| Beginning Cash Position | $5,133,000,000 | $4,076,000,000 | $4,745,000,000 | $3,382,000,000 |
| Effect Of Exchange Rate Changes | $-3,000,000 | $-9,000,000 | $-8,000,000 | $-25,000,000 |
| Changes In Cash | $-1,256,000,000 | $1,066,000,000 | $-661,000,000 | $1,279,000,000 |
| Common Stock Payments | $-765,000,000 | $-750,000,000 | $-2,000,000,000 | $-1,000,000,000 |
| Net Issuance Payments Of Debt | $3,224,000,000 | $356,000,000 | $-579,000,000 | $-885,000,000 |
| Net Long Term Debt Issuance | $3,224,000,000 | $356,000,000 | $-579,000,000 | $-885,000,000 |
| Long Term Debt Payments | $-445,000,000 | $-783,000,000 | $-579,000,000 | $-885,000,000 |
| Long Term Debt Issuance | $3,669,000,000 | $1,139,000,000 | $0 | $0 |
| Net Investment Purchase And Sale | $202,000,000 | $-166,000,000 | $29,000,000 | $22,000,000 |
| Sale Of Investment | $202,000,000 | $384,000,000 | $29,000,000 | $100,000,000 |
| Purchase Of Investment | $0 | $-550,000,000 | $0 | $-78,000,000 |
| Net Business Purchase And Sale | $-5,250,000,000 | $-1,190,000,000 | $-10,000,000 | $901,000,000 |
| Purchase Of Business | $-5,250,000,000 | $-1,190,000,000 | $-10,000,000 | $-22,000,000 |
| Net PPE Purchase And Sale | $-547,000,000 | $-511,000,000 | $-481,000,000 | $-356,000,000 |
| Purchase Of PPE | $-547,000,000 | $-511,000,000 | $-481,000,000 | $-387,000,000 |
| Change In Working Capital | $-523,000,000 | $1,510,000,000 | $457,000,000 | $1,210,000,000 |
| Change In Payables And Accrued Expense | $2,126,000,000 | $1,391,000,000 | $1,819,000,000 | $3,819,000,000 |
| Change In Accrued Expense | $-606,000,000 | $-433,000,000 | $-997,000,000 | $264,000,000 |
| Change In Payable | $2,732,000,000 | $1,824,000,000 | $2,816,000,000 | $3,555,000,000 |
| Change In Account Payable | $2,732,000,000 | $1,824,000,000 | $2,816,000,000 | $3,555,000,000 |
| Change In Inventory | $-1,816,000,000 | $1,115,000,000 | $-412,000,000 | $-1,204,000,000 |
| Change In Receivables | $-833,000,000 | $-996,000,000 | $-950,000,000 | $-1,405,000,000 |
| Changes In Account Receivables | $-833,000,000 | $-996,000,000 | $-950,000,000 | $-1,405,000,000 |
| Stock Based Compensation | $244,000,000 | $121,000,000 | $96,000,000 | $81,000,000 |
| Provisionand Write Offof Assets | $53,000,000 | $36,000,000 | $55,000,000 | $23,000,000 |
| Asset Impairment Charge | $21,000,000 | $636,000,000 | $1,253,000,000 | $2,084,000,000 |
| Deferred Tax | $243,000,000 | $-104,000,000 | $-40,000,000 | $14,000,000 |
| Deferred Income Tax | $243,000,000 | $-104,000,000 | $-40,000,000 | $14,000,000 |
| Depreciation Amortization Depletion | $790,000,000 | $710,000,000 | $692,000,000 | $692,000,000 |
| Depreciation And Amortization | $790,000,000 | $710,000,000 | $692,000,000 | $692,000,000 |
| Net Income From Continuing Operations | $1,569,000,000 | $853,000,000 | $331,000,000 | $-937,000,000 |
| Other Cash Adjustment Outside Changein Cash | - | $0 | $0 | $109,000,000 |
| Sale Of Business | - | $9,000,000 | $0 | $923,000,000 |
| Sale Of PPE | - | $12,000,000 | $12,000,000 | $31,000,000 |
| Gain Loss On Sale Of Business | - | $0 | $0 | $-2,000,000 |
| Net Short Term Debt Issuance | - | - | - | $0 |
| Earnings Losses From Equity Investments | - | - | - | - |
Fetched: 2026-07-08